DBV Technologies S.A.

BATS-CHIXE:DBVP Stock Report

Market Cap: €284.7m

DBV Technologies Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Daniel Tassé

Chief executive officer

US$2.9m

Total compensation

CEO salary percentage20.5%
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenure4.3yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Daniel Tassé's remuneration changed compared to DBV Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-US$101m

Mar 31 2023n/an/a

-US$100m

Dec 31 2022US$3mUS$600k

-US$96m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$77m

Mar 31 2022n/an/a

-US$85m

Dec 31 2021US$2mUS$600k

-US$98m

Sep 30 2021n/an/a

-US$124m

Jun 30 2021n/an/a

-US$131m

Mar 31 2021n/an/a

-US$148m

Dec 31 2020US$2mUS$600k

-US$160m

Sep 30 2020n/an/a

-US$161m

Jun 30 2020n/an/a

-US$171m

Mar 31 2020n/an/a

-US$169m

Dec 31 2019US$3mUS$600k

-US$172m

Sep 30 2019n/an/a

-US$176m

Jun 30 2019n/an/a

-US$198m

Mar 31 2019n/an/a

-US$191m

Dec 31 2018US$5mUS$55k

-US$190m

Compensation vs Market: Daniel's total compensation ($USD2.93M) is above average for companies of similar size in the UK market ($USD1.02M).

Compensation vs Earnings: Daniel's compensation has increased whilst the company is unprofitable.

CEO

Daniel Tassé (63 yo)

4.8yrs

Tenure

US$2,931,640

Compensation

Mr. Daniel Tasse had been an Independent Non-Executive Director of Indivior PLC since August 2014 until May 6, 2021 and Senior Independent Director since September 30, 2016 until May 6, 2021. Mr. Tasse ser...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Tassé
CEO & Director4.8yrsUS$2.93mno data
Sébastien Robitaille
Chief Financial Officer2.8yrsUS$501.63k0.021%
€ 61.0k
Pharis Mohideen
Chief Medical Officer4.1yrsUS$1.08m0.010%
€ 29.4k
Pascal Wotling
Chief Technical Operations Officer & Chief Quality Officer3.3yrsno datano data
Anne Pollak
Head of Investor Relationsno datano datano data
Michele Robertson
Chief Legal Officer2.5yrsno datano data
Joseph Becker
Vice President of Global Corporate Communicationsno datano datano data
Caroline Daniere
Chief Human Resources Officer & Chief of Staff3.9yrsno datano data
Wence Agbotounou
Chief Clinical Trial Officer & Senior VP7.3yrsno datano data
Edward Jordan
Senior Vice President of Commercial Operations North America7.6yrsno datano data
Alan Kerr
Senior VP & Head of Global Regulatory Affairs4.6yrsno datano data
Nathalie Donne
Vice President of Strategy Commercial Operations Europe & Alliance Management7.3yrsno datano data

4.3yrs

Average Tenure

55yo

Average Age

Experienced Management: DBVP's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Daniel Tassé
CEO & Director4.4yrsUS$2.93mno data
Timothy Morris
Independent Director2.4yrsUS$115.17k0%
€ 0
Michel de Rosen
Independent Chairman of the Board5.3yrsUS$15.90k0.025%
€ 69.8k
Michael Goller
Director7.8yrsUS$116.59k0%
€ 0
Daniel Soland
Independent Director8.4yrsUS$111.29k0.021%
€ 59.2k
Mailys Ferrere
Director7.2yrsno datano data
Hugh Sampson
Scientific Adviser to the CEO & Chairman of Scientific Advisory Board2.7yrsno datano data
Paul-Henri Lambert
Member of the Scientific Advisory Boardno datano datano data
Emma Guttman-Yassky
Member of Scientific Advisory Board4.3yrsno datano data
Julie O'Neill
Director6.2yrsUS$105.99k0%
€ 0
Jean-François Nicolas
Member of Scientific Advisory Board4.3yrsno datano data
Jim Krueger
Member of Scientific Advisory Board4.3yrsno datano data

4.4yrs

Average Tenure

63yo

Average Age

Experienced Board: DBVP's board of directors are considered experienced (4.4 years average tenure).